老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enlivex Therapeutics Ltd.

0.8827
+0.01822.11%
盤後：0.90160.0189+2.14%19:30 EDT
成交量：22.94萬
成交額：20.53萬
市值：1,543.45萬
市盈率：0.00
高：0.9200
開：0.8800
低：0.8700
收：0.8645
52周最高：27.15
52周最低：0.8637
股本：1,748.55萬
流通股本：532.27萬
量比：0.87
換手率：4.31%
股息：- -
股息率：- -
每股收益(TTM):382.20
每股收益(LYR):382.20
淨資產收益率：126.17%
總資產收益率：-0.80%
市淨率：0.01
市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告
2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/01/31

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/23

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/05

SEC問詢函

[Cover]Correspondence
2019/06/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/26

超過5%披露

Statement of acquisition of beneficial ownership by individuals
更多